Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hirsch

Showing results (561-570 of 597) with videos related to

Pageof 60
Sort By:
Cell Death and Differentiation|July 15, 2018
Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activityLayal Maatouk, Chenju Yi, Maria-Angeles Carrillo-de Sauvage, et al.
The Journal of Clinical Investigation|December 24, 2008
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson diseaseVanessa Brochard, Béhazine Combadière, Annick Prigent, et al.
Scientific Reports|January 16, 2023
Author Correction: Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson diseaseCarmen Noelker, Lydie Morel, Thomas Lescot, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 31, 2013
Timing of neonatal cardiac surgery is not associated with perioperative outcomesT K Susheel Kumar, John R Charpie, Richard G Ohye, et al.
Scientific Reports|March 7, 2013
Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson diseaseCarmen Noelker, Lydie Morel, Thomas Lescot, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2008
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's diseaseJulio Salazar, Natalia Mena, Stephane Hunot, et al.
Leukemia|October 25, 2016
Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasmsV Visconte, B Przychodzen, Y Han, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 28, 2021
Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trialMarijn Lijffijt, Nicholas Murphy, Sidra Iqbal, et al.
Journal of Neuroinflammation|June 3, 2014
Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson diseaseCarmen Noelker, Lydie Morel, Anke Osterloh, et al.
Leukemia|August 26, 2016
Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomideE Negoro, T Radivoyevitch, C Polprasert, et al.
Pageof 60

Showing results (561-570 of 597) with videos related to

Sort By:
Pageof 60
Cell Death and Differentiation|July 15, 2018
Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activityLayal Maatouk, Chenju Yi, Maria-Angeles Carrillo-de Sauvage, et al.
The Journal of Clinical Investigation|December 24, 2008
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson diseaseVanessa Brochard, Béhazine Combadière, Annick Prigent, et al.
Scientific Reports|January 16, 2023
Author Correction: Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson diseaseCarmen Noelker, Lydie Morel, Thomas Lescot, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 31, 2013
Timing of neonatal cardiac surgery is not associated with perioperative outcomesT K Susheel Kumar, John R Charpie, Richard G Ohye, et al.
Scientific Reports|March 7, 2013
Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson diseaseCarmen Noelker, Lydie Morel, Thomas Lescot, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2008
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's diseaseJulio Salazar, Natalia Mena, Stephane Hunot, et al.
Leukemia|October 25, 2016
Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasmsV Visconte, B Przychodzen, Y Han, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 28, 2021
Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trialMarijn Lijffijt, Nicholas Murphy, Sidra Iqbal, et al.
Journal of Neuroinflammation|June 3, 2014
Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson diseaseCarmen Noelker, Lydie Morel, Anke Osterloh, et al.
Leukemia|August 26, 2016
Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomideE Negoro, T Radivoyevitch, C Polprasert, et al.
Pageof 60